Purpose: Although moderate- to high-intensity statin therapy is increasingly recommended in cardiovascular disease patients, the efficacy and safety in elderly patients have not been proven clearly. Here, we compare the effect of various-intensity statins between elderly and very elderly patients. ...
Accordingly, we designed the ASTEROID trial (A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden) to examine the effects of high-intensity statin therapy on IVUS-derived measures of coronary disease progression. Rosuvastatin is the most recently ...
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295(13):1556-1565. doi:10.1001/jama.295.13.jpc60002ArticlePubMedGoogle ScholarCrossref 12. Kini AS, Baber U, Kovacic JC, et al. Changes in plaque lipid ...
To achieve the Apo B target of 90 mg/dL, statin therapy required 20-30 mg/dL lower targets for both LDL-C and non-HDL-C. The strong correlation between Apo B and non-HDL-C on statin therapy (R2 = 0.88−0.92) suggests that non-HDL-C may be a useful surrogate for Apo B in ...
Benes LB, Bassi NS, Davidson MH. The risk of hepatotox- icity, new onset diabetes and rhabdomyolysis in the era of high-intensity statin therapy: does statin type mat- ter? Progress Cardiovasc Dis 2016; 59: 145-52.Benes, L. B., Bassi, N. S., and Davidson, M. H. (2016). The ...
Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels_ A Meta-Analysis_2021_J 上传人:jrlib7·上传时间:2022-11-27 继续阅读
High-Dose Statin Therapy for Secondary Prevention of Stroke High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review. J Cardiovasc Nurs. ... DW Schwertz,KO Badellino - 《Journal of Cardiovascular Nursing》 被引量: 0...
Compliance with statin therapy high in Denmarkdoi:10.1007/BF03279174NoneSpringer International PublishingPharmacoeconomics & Outcomes News
3-5 Many patients receiving moderate- or high-intensity statin therapy are unable to achieve these recommended goals with statin therapy, and consideration of nonstatin therapy for additional LDL-C lowering has been recommended.4-8 Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors ...
High-Dose Statin Therapy Has Expanded Benefits.High-Dose Statin Therapy Has Expanded Benefits.The article offers information on the results of a study on the expanded benefits of high-dose statin treatment for patients with coronary heart disease (CHD) and those who are at risk of chronic kidney...